Home Nucleus Oncology U.K. Gastric Cancer Diagnostics Market to 2032

U.K. Gastric Cancer Diagnostics Market to 2032

Overview

The U.K. Gastric Cancer Diagnostics Market is expected to reach a 71.72 USD Million by 2032 and is projected to grow at a CAGR of 11.38% from 2025 to 2032.

Revenue, 2024 (USD Million)
38.91
Forecast, 2032 (USD Million)
71.72
CAGR, 2024 - 2032
11.38%
Report Coverage
U.K.

U.K. Gastric Cancer Diagnostics Market 2018-2032 USD Million

U.K. Gastric Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 38.91 USD Million
  • Projected Market Size (2032): 71.72 USD Million
  • CAGR (2025-2032): 11.38%

Key Findings of U.K. Gastric Cancer Diagnostics Market

  • The U.K. Gastric Cancer Diagnostics Market was valued at 38.91 USD Million in 2024.
  • The U.K. Gastric Cancer Diagnostics Market is likely to grow at a CAGR of 11.38% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 24.75 USD Million
  • The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 14.47% during the forecast period from 2024 to 2032.

U.K. Gastric Cancer Diagnostics Market Scope

U.K. Gastric Cancer Diagnostics Market Segmentation & Scope
Product Type
  • Services
  • Instruments
  • Reagents & Consumables
Diagnostic Type
  • Gastric Cancer Screening Tests/Physical Exam
  • Confirmatory Test
Stage
  • Stage 0
  • Stage III
  • Stage II
  • Stage I
Gender
  • Female
  • Male
Sample Type
  • Urine
  • Blood
  • Tissue
  • Stool
End User
  • Others
  • Oncology Speciality Clinics
  • Cancer Research Institutes
  • Diagnostic Laboratories
  • Hospitals
Age Group
  • Pediatric
  • Adult
  • Geriatrics
Disease Type
  • Others
  • Gastric Lymphoma
  • Gastrointestinal Stromal Tumor
  • Carcinoid tumor
  • Intestinal or Diffuse Adinocarcinoma
Distribution Channel
  • Retail Sales
  • Direct Tender

U.K. Gastric Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 38.91 USD Million
Market Value in 2032 71.72 USD Million
CAGR (2025-2032) 11.38%
Historic Data 2016-2023
Market Segments Covered Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 38.91 USD Million in 2024
    • Key Country: U.K., leading in terms of revenue with value of 38.91 USD Million in 2024.

Segments and Scope

  • U.K. Gastric Cancer Diagnostics Market to 2032, By Product Type
    • Reagents & Consumables is the largest segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a revenue of 21.64 USD Million in the year 2024.
    • Reagents & Consumables is the Fastest growing segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.33 % in forecast period 2025-2032.
  • U.K. Gastric Cancer Diagnostics Market to 2032, By Diagnostic Type
    • Confirmatory Test is the largest segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a revenue of 22.49 USD Million in the year 2024.
    • Confirmatory Test is the Fastest growing segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.41 % in forecast period 2025-2032.
  • U.K. Gastric Cancer Diagnostics Market to 2032, By Stage
    • Stage I is the largest segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a revenue of 14.71 USD Million in the year 2024.
    • Stage I is the Fastest growing segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.89 % in forecast period 2025-2032.
  • U.K. Gastric Cancer Diagnostics Market to 2032, By Gender
    • Male is the largest segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a revenue of 21.10 USD Million in the year 2024.
    • Male is the Fastest growing segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.72 % in forecast period 2025-2032.
  • U.K. Gastric Cancer Diagnostics Market to 2032, By Sample Type
    • Stool is the largest segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a revenue of 15.89 USD Million in the year 2024.
    • Stool is the Fastest growing segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 14.40 % in forecast period 2025-2032.
  • U.K. Gastric Cancer Diagnostics Market to 2032, By End User
    • Hospitals is the largest segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a revenue of 13.54 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 14.47 % in forecast period 2025-2032.
  • U.K. Gastric Cancer Diagnostics Market to 2032, By Age Group
    • Geriatrics is the largest segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a revenue of 20.98 USD Million in the year 2024.
    • Geriatrics is the Fastest growing segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.81 % in forecast period 2025-2032.
  • U.K. Gastric Cancer Diagnostics Market to 2032, By Disease Type
    • Intestinal or Diffuse Adinocarcinoma is the largest segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a revenue of 17.12 USD Million in the year 2024.
    • Intestinal or Diffuse Adinocarcinoma is the Fastest growing segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 14.10 % in forecast period 2025-2032.
  • U.K. Gastric Cancer Diagnostics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a revenue of 24.75 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in U.K. Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.39 % in forecast period 2025-2032.

U.K. Gastric Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Myriad Genetics, Inc.
BIOMÉRIEUX
Abbott
General Electric
F. Hoffmann-La Roche Ltd.
U.K. Gastric Cancer Diagnostics Market Company Share Analysis

U.K. Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Gastric Cancer Diagnostics Market Company Profiling

U.K. Gastric Cancer Diagnostics Market Company Profiling

Industry Related Reports

Asia-Pacific Breast Lesion Localization Methods Market
Europe Breast Lesion Localization Methods Market
North America Breast Lesion Localization Methods Market
Middle East & Africa Breast Lesion Localization Methods Market
South America Breast Lesion Localization Methods Market
Australia Breast Lesion Localization Methods Market
Belgium Breast Lesion Localization Methods Market
Brazil Breast Lesion Localization Methods Market
Canada Breast Lesion Localization Methods Market
China Breast Lesion Localization Methods Market
Frequently Asked Questions
The U.K. Gastric Cancer Diagnostics Market is segmented based on Segmentation Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type,Distribution Channel.
U.K. Gastric Cancer Diagnostics Market was valued at USD 38.91(Revenue in USD Million) in 2020.
U.K. Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 11.38% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the U.K. Gastric Cancer Diagnostics Market, holding a largest market share of 24.75 USD Million in 2024

U.K. Gastric Cancer Diagnostics Market Scope

U.K. Gastric Cancer Diagnostics Market Segmentation & Scope
Product Type
  • Services
  • Instruments
  • Reagents & Consumables
Diagnostic Type
  • Gastric Cancer Screening Tests/Physical Exam
  • Confirmatory Test
Stage
  • Stage 0
  • Stage III
  • Stage II
  • Stage I
Gender
  • Female
  • Male
Sample Type
  • Urine
  • Blood
  • Tissue
  • Stool
End User
  • Others
  • Oncology Speciality Clinics
  • Cancer Research Institutes
  • Diagnostic Laboratories
  • Hospitals
Age Group
  • Pediatric
  • Adult
  • Geriatrics
Disease Type
  • Others
  • Gastric Lymphoma
  • Gastrointestinal Stromal Tumor
  • Carcinoid tumor
  • Intestinal or Diffuse Adinocarcinoma
Distribution Channel
  • Retail Sales
  • Direct Tender
Frequently Asked Questions
The U.K. Gastric Cancer Diagnostics Market is segmented based on Segmentation Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type,Distribution Channel.
U.K. Gastric Cancer Diagnostics Market was valued at USD 38.91(Revenue in USD Million) in 2020.
U.K. Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 11.38% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Gastric Cancer Diagnostics Market for final year is USD 71.72 (USD Million).

U.K. Gastric Cancer Diagnostics Market Company Profiling

U.K. Gastric Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The U.K. Gastric Cancer Diagnostics Market is segmented based on Segmentation Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type,Distribution Channel.
U.K. Gastric Cancer Diagnostics Market was valued at USD 38.91(Revenue in USD Million) in 2020.
U.K. Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 11.38% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Gastric Cancer Diagnostics Market for final year is USD 71.72 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES